Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice
- 1 July 2006
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 98 (1), 33-37
- https://doi.org/10.1111/j.1464-410x.2006.06189.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practiceBJU International, 2005
- Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?BJU International, 2005
- FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell CarcinomaCancer Research, 2004
- The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancerUrologic Oncology, 2004
- High-Throughput Tissue Microarray Analysis of erbB-2 Gene Amplification in Urinary Bladder CancerUrologia Internationalis, 2003
- Multitarget Fluorescence In Situ Hybridization Assay Detects Transitional Cell Carcinoma in the Majority of Patients with Bladder Cancer and Atypical or Negative Urine CytologyJournal of Urology, 2003
- Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder CancerJournal of Urology, 2002
- A Comparison of BTA Stat, Hemoglobin Dipstick, Telomerase and Vysis Urovysion Assays for the Detection of Urothelial Carcinoma in UrineJournal of Urology, 2002
- Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalitiesHuman Genetics, 1997
- Chromosome changes in early bladder neoplasmsJournal of Cellular Biochemistry, 1992